CONMED Corp — Director's Dealing 2021

Nov 9, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2021-11-05

Reporting Person: TRYNISKI MARK E (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-05	Common Stock	M	4892	$51.90	Acquired	13188	Direct
2021-11-05	Common Stock	S	4792	$156.508	Disposed	8396	Direct
2021-11-05	Common Stock	S	100	$157.11	Disposed	8296	Direct
2021-11-05	Common Stock	M	3399	$69.03	Acquired	11695	Direct
2021-11-05	Common Stock	S	2899	$156.439	Disposed	8796	Direct
2021-11-05	Common Stock	S	500	$157.061	Disposed	8296	Direct
2021-11-05	Common Stock	M	2886	$79.94	Acquired	11182	Direct
2021-11-05	Common Stock	S	2386	$156.436	Disposed	8796	Direct
2021-11-05	Common Stock	S	500	$156.949	Disposed	8296	Direct
2021-11-05	Common Stock	M	1843	$73.94	Acquired	10139	Direct
2021-11-05	Common Stock	S	1743	$156.483	Disposed	8396	Direct
2021-11-05	Common Stock	S	100	$157.05	Disposed	8296	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-05	Options To Purchase Common Stock	$51.90	M	4892	Disposed	2027-06-01	Common Stock (4892)	Direct
2021-11-05	Options To Purchase Common Stock	$69.03	M	3399	Disposed	2028-06-01	Common Stock (3399)	Direct
2021-11-05	Options To Purchase Common Stock	$79.94	M	2886	Disposed	2029-06-03	Common Stock (2886)	Direct
2021-11-05	Options To Purchase Common Stock	$73.94	M	1843	Disposed	2030-06-01	Common Stock (1843)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.01 to $156.96. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $155.82 to $156.81. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.83 to $157.37. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $155.81 to $156.76. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.

F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.86 to $157.12. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.

F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.01 to $156.96. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.

F7: The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period.

F8: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period.